5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum

Neuropsychopharmacology

Volumn 26, Issue 3, 2002, Pages 311-324

  Porras, Grégory ^a   Di Matteo, Vincenzo ^b   Fracasso, Claudia ^b   Lucas, Guillaume ^a   De Deurwaerdère, Philippe ^a   Caccia, Silvio ^b   Esposito, Ennio ^b   Spampinato, Umberto ^a  

^a CNRS   (France)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

5 HT2A receptors; 5 HT2C 2B receptors; Amphetamine; Dopamine release; Dopaminergic neuron firing rate; Microdialysis; Morphine

Indexed keywords

1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; AMPHETAMINE; DOPAMINE; DRUG VEHICLE; EPLIVANSERIN; MORPHINE; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; DOPAMINE UPTAKE INHIBITOR; NARCOTIC ANALGESIC AGENT; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; MALE; MICRODIALYSIS; NERVE CELL; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTUM; ANIMAL; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY; SECRETION; SPRAGUE DAWLEY RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

AMPHETAMINE; ANALGESICS, OPIOID; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MALE; MORPHINE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2B; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0036008435     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00333-5     Document Type: Article

References (55)

1. Serotonin-facilitated dopamine release in vivo: Pharmacological characterisation
2. Distribution of morphine in brain regions, spinal cord and serum following intravenous injection to morphine tolerant rats
3. Morphine concentrations in serum, brain and cerebrospinal fluid in the rat after intravenous administration of a single dose
4. 4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: A microdialysis study in the halothane-anesthetized rat
5. Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity
6. Oral kinetics of dexfenfluramine and dexnorfenfluramine in non-human primates
7. Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: Evidence from microdialysis and Fos immunohistochemistry
8. Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells
9. 3 antagonist on drug-induced stimulation of dopamine release
10. 2B/2C receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation
11. 3 receptors
12. Modulation of striatal metabolism by the activity of dorsal raphe serotonergic afferences
13. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
14. Neurobiology of opiate abuse
15. 2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: A combined in vivo electrophysiological and microdialysis study
16. 2C receptor antagonist
17. Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system
18. 2C receptor messenger RNA in the basal ganglia of adult rats
19. The pharmacological profile of some psychomotor stimulant drugs including chemical, neurophysiological, biochemical and toxicological aspects
20. 2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats
21. 2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat
22. Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists
23. Morphine-induced activation of A10 dopamine neurons in the rat
24. Ca2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission
25. 2C/2B receptor antagonists: Neurochemical and behavioural studies
26. Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens
27. 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum
28. Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis
29. 3 receptor antagonist MDL 72222 dose-dependently attenuates cocaine- and amphetamine-induced elevations of extracellular dopamine in the nucleus accumbens and the dorsal striatum
30. Serotonin-dopamine interaction and its relevance to schizophrenia
31. 2B receptor antagonist with anxiolytic-like properties
32. Drug addiction, dysregulation of reward, and allostasis
33. Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat
34. 2A receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex, but inhibits that in the nucleus accumbens
35. 2C receptor subtypes in the control of in vivo dopamine release in the rat striatum
36. 2C receptor subtypes and significance of the haloperidol dose used
37. Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated
38. The role of serotonin in antipsychotic drug action
39. 2A sites for PCP-induced locomotion in the rat
40. Diffusion of morphine-6-beta-D-glucuronide into the neonatal guinea pig brain during drug-induced respiratory depression
41. Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis
42. Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated
43. 2C receptors
44. 4 receptor antagonist, attenuates morphine-stimulated dopamine release in the rat striatum
45. 2A receptor blockade
46. 2 receptors exert a state-dependent regulation of dopaminergic function: Studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine
47. 1A agonists
48. Amphetamine: Effects on catecholamine systems and behavior
49. 2A antagonist MDL 100 907 blocks dizocilpine-induced increases in the firing rate of A10 dopamine neurons
50. 4 receptor ligands to modulate rat striatal dopamine release in vitro or in vivo
51. Determination of codeine and metabolites in plasma and urine using ion-pair high-performance liquid chromatography
52. Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine
53. Dopaminergic neurons in the rat ventral tegmental area. I. Identification and characterization
54. 2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens